Can you take lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) and metoprolol (beta blocker) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Taking Lisinopril and Metoprolol Together

Yes, lisinopril (an ACE inhibitor) and metoprolol (a beta blocker) can be safely taken together and are often prescribed in combination for certain cardiovascular conditions. This combination is supported by clinical guidelines and can provide complementary blood pressure-lowering effects through different mechanisms.

Mechanism of Action and Rationale

  • Lisinopril: ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and sodium retention 1
  • Metoprolol: Beta-blocker that reduces heart rate and cardiac output by blocking beta-adrenergic receptors 1

The combination works well because these medications target different pathways in blood pressure regulation:

  • Lisinopril affects the renin-angiotensin-aldosterone system
  • Metoprolol affects the sympathetic nervous system

Clinical Applications

This combination is particularly beneficial for patients with:

  • Hypertension with inadequate control on monotherapy 1, 2
  • Heart failure with reduced ejection fraction (HFrEF) - metoprolol succinate and bisoprolol are preferred beta blockers for HFrEF 1
  • Post-myocardial infarction - both medications have cardioprotective effects
  • Hypertension with coronary artery disease 2

Efficacy

  • Studies have shown that combining medications from different antihypertensive classes provides more effective blood pressure control than increasing the dose of a single agent 1
  • The combination can provide greater systolic blood pressure reduction than either agent alone 3

Important Considerations

  1. Monitoring requirements:

    • Blood pressure should be monitored regularly
    • Renal function and potassium levels should be checked within 3 months of starting therapy and periodically thereafter 2
  2. Potential side effects:

    • Hypotension (especially when initiating therapy)
    • Bradycardia (from metoprolol)
    • Cough (from lisinopril)
    • Hyperkalemia (from lisinopril)
  3. Contraindications:

    • Avoid in pregnancy (lisinopril is contraindicated) 1
    • Use with caution in patients with severe renal impairment 4
    • Use with caution in patients with reactive airways disease (metoprolol, though cardioselective, may still affect airways) 1

Dosing Considerations

  • Lisinopril: Typical dosing range is 10-40 mg once daily 1, 4
  • Metoprolol: Available as immediate-release (tartrate) 100-200 mg twice daily or extended-release (succinate) 50-200 mg once daily 1
  • When combining these medications, start with lower doses and titrate as needed

Important Caution

While lisinopril and metoprolol can be safely combined, avoid combining:

  • Two ACE inhibitors together
  • An ACE inhibitor with an ARB (angiotensin receptor blocker)
  • An ACE inhibitor or ARB with a direct renin inhibitor (aliskiren)

These combinations targeting the same system can increase cardiovascular and renal risks without additional benefit 1.

Summary

Lisinopril and metoprolol combination therapy is a well-established approach for treating hypertension and certain cardiovascular conditions. The combination provides complementary mechanisms of action that can lead to more effective blood pressure control with potentially fewer side effects than higher doses of either medication alone.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The clinical pharmacology of lisinopril.

Journal of cardiovascular pharmacology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.